Champions Oncology

Champions Oncology, Inc. is a biotechnology company that specializes in developing and selling technology solutions aimed at personalizing oncology drug development and treatment. Headquartered in Hackensack, New Jersey, the company utilizes its Tumorgraft Technology Platform, which involves implanting human tumors in immune-deficient mice, to deliver Personalized Oncology Solutions (POS). These solutions aid physicians in crafting tailored treatment plans by providing tumor-specific data from drug panels. Additionally, Champions Oncology offers Translational Oncology Solutions (TOS) that support pharmaceutical and biotechnology companies in their drug development processes. The company's product offerings include TumorGraft implants and drug panels that evaluate how a patient's tumor responds to various oncology drugs or combinations. Founded in 1985 and previously known as Champions Biotechnology, Inc., Champions Oncology is committed to enhancing cancer treatment outcomes through innovative technologies.